22nd Century Group Inc (NYSEAMERICAN:XXII) shot up 10% on Monday . The stock traded as high as $2.69 and last traded at $2.65. 5,866,800 shares changed hands during trading, an increase of 172% from the average session volume of 2,157,709 shares. The stock had previously closed at $2.41.

Several brokerages recently weighed in on XXII. Zacks Investment Research raised shares of 22nd Century Group from a “sell” rating to a “hold” rating and set a $3.00 price target for the company in a research report on Wednesday, October 18th. Chardan Capital raised their price target on shares of 22nd Century Group from $3.50 to $11.50 and gave the company a “buy” rating in a research report on Monday, October 16th.

22nd Century Group (NYSEAMERICAN:XXII) last posted its earnings results on Thursday, November 9th. The biotechnology company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.01). 22nd Century Group had a negative return on equity of 50.30% and a negative net margin of 73.20%. The company had revenue of $4.53 million during the quarter, compared to the consensus estimate of $5.09 million. During the same period last year, the firm posted ($0.03) EPS. The company’s revenue for the quarter was up 46.1% on a year-over-year basis.

In other news, VP Michael Robert Moynihan sold 50,000 shares of the business’s stock in a transaction on Friday, September 29th. The shares were sold at an average price of $2.67, for a total transaction of $133,500.00. Following the completion of the sale, the vice president now owns 867,220 shares of the company’s stock, valued at approximately $2,315,477.40. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its stake in 22nd Century Group by 17.6% in the 2nd quarter. Vanguard Group Inc. now owns 2,894,322 shares of the biotechnology company’s stock worth $5,065,000 after purchasing an additional 432,450 shares in the last quarter. Virtu KCG Holdings LLC lifted its stake in 22nd Century Group by 300.9% in the 2nd quarter. Virtu KCG Holdings LLC now owns 126,106 shares of the biotechnology company’s stock worth $221,000 after purchasing an additional 94,650 shares in the last quarter. Advisor Group Inc. lifted its stake in 22nd Century Group by 49.3% in the 3rd quarter. Advisor Group Inc. now owns 73,775 shares of the biotechnology company’s stock worth $204,000 after purchasing an additional 24,375 shares in the last quarter. Bristol Advisors LLC purchased a new stake in 22nd Century Group in the 3rd quarter worth $201,000. Finally, Steward Partners Investment Advisory LLC purchased a new stake in 22nd Century Group in the 3rd quarter worth $100,000.

TRADEMARK VIOLATION NOTICE: “22nd Century Group (XXII) Shares Up 10%” was published by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://www.watchlistnews.com/22nd-century-group-xxii-shares-up-10/1758127.html.

About 22nd Century Group

Receive News & Ratings for 22nd Century Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.